BPC
IOVA icon

Banque Pictet & Cie’s Iovance Biotherapeutics IOVA Stock Holding History

Banque Pictet & Cie’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-62,121
Closed -$107K – 408
2025
Q2 		$107K Sell
62,121
-4,173
-6% -$10.4K ﹤0.01% 356
2025
Q1 		$221K Sell
66,294
-310,297
-82% -$1.6M ﹤0.01% 376
2024
Q4 		$2.79M Buy
376,591
+54,832
+17% +$508K 0.02% 198
2024
Q3 		$3.02M Sell
321,759
-346,891
-52% -$3.29M 0.02% 171
2024
Q2 		$5.36M Sell
668,650
-20,706
-3% -$222K 0.05% 144
2024
Q1 		$10.2M Sell
689,356
-88,682
-11% -$1.03M 0.1% 89
2023
Q4 		$6.33M Buy
778,038
+144,244
+23% +$755K 0.05% 138
2023
Q3 		$2.88M Buy
633,794
+99,636
+19% +$651K 0.03% 179
2023
Q2 		$3.76M Sell
534,158
-138,730
-21% -$993K 0.03% 182
2023
Q1 		$4.11M Buy
672,888
+106,316
+19% +$734K 0.04% 192
2022
Q4 		$3.62M Sell
566,572
-29,040
-5% -$227K 0.04% 211
2022
Q3 		$5.71M Sell
595,612
-88,721
-13% -$1.02M 0.06% 163
2022
Q2 		$7.55M Buy
684,333
+148,563
+28% +$1.95M 0.07% 122
2022
Q1 		$8.92M Buy
535,770
+1,734
+0.3% +$26.8K 0.07% 130
2021
Q4 		$10.2M Buy
534,036
+467,364
+701% +$10.3M 0.08% 130
2021
Q3 		$1.64M Buy
66,672
+7,552
+13% +$178K 0.02% 216
2021
Q2 		$1.54M Buy
59,120
+41,523
+236% +$1.08M 0.02% 222
2021
Q1 		$557K Buy
+17,597
New +$729K 0.01% 288

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Banque Pictet & Cie's IOVA Position: Q3 2025 in Review

Banque Pictet & Cie sold out of Iovance Biotherapeutics (IOVA) in Q3 2025, closing a stake of 62,121 shares — an estimated $107K sold.

Banque Pictet & Cie first reported a position in IOVA in Q1 2021 and held it in 18 quarters. The position peaked at $10.2M in Q1 2024. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Banque Pictet & Cie reported no remaining Iovance Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Banque Pictet & Cie sold 62,121 Iovance Biotherapeutics shares in Q3 2025, an estimated $107K.
  • Banque Pictet & Cie first reported a position in Iovance Biotherapeutics in Q1 2021 and held it in 18 quarters.
  • Banque Pictet & Cie's Iovance Biotherapeutics position peaked at $10.2M in Q1 2024.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Banque Pictet & Cie's 13F filing for Q3 2025, filed 21 Oct 2025.